HOLOGIC INC shareholders Q4 2021

HOLOGIC INC's ticker is HOLX and the CUSIP is 436440101. A total of 670 filers reported holding HOLOGIC INC in Q4 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

HOLOGIC INC shareholders Q4 2021
NameSharesValueWeighting ↓
Blue Door Asset Management, LLC 93,740$7,177,0006.59%
Pavadi Capital LLC 71,138$5,446,0004.13%
Endurant Capital Management LP 181,068$13,863,0003.35%
Iron Triangle Partners LP 280,000$21,437,0002.99%
Trinity Street Asset Management LLP 303,587$23,242,0002.55%
ATWOOD & PALMER INC 324,636$24,854,0002.08%
Otter Creek Advisors, LLC 40,793$3,124,0002.02%
McGuire Investment Group, LLC 145,959$11,175,0001.84%
Avidity Partners Management LP 1,064,000$81,460,0001.73%
Lombard Odier Asset Management (Switzerland) SA 326,434$24,992,0001.60%
Bradley Mark J. 31,725$2,429,0001.59%
Eagle Ridge Investment Management 186,714$14,295,0001.50%
LaFleur & Godfrey LLC 147,811$11,316,0001.45%
FORMULA GROWTH LTD 105,073$8,044,0001.43%
Ellsworth Advisors, LLC 47,248$3,617,0001.34%
Sivik Global Healthcare LLC 40,000$3,062,0001.31%
Rodgers Brothers Inc. 86,485$6,621,0001.18%
CLOUGH CAPITAL PARTNERS L P 228,020$17,457,0001.17%
FIRST COMMUNITY TRUST NA 17,175$1,314,918,0001.09%
NORTH STAR ASSET MANAGEMENT INC 257,856$19,741,0000.99%
About HOLOGIC INC

Hologic Inc: A Leader in Women's Health

Hologic Inc is a medical technology company that specializes in women's health. The company is headquartered in Marlborough, Massachusetts, and has operations in over 50 countries worldwide. Hologic's mission is to improve women's health through early detection and treatment of diseases such as breast cancer, cervical cancer, and osteoporosis.

Hologic's flagship product is the Genius 3D Mammography system, which is the first and only FDA-approved 3D mammography system. The system provides better detection of breast cancer than traditional 2D mammography, and reduces the need for additional imaging and biopsies. Hologic also offers a range of other products for breast cancer screening and diagnosis, including breast biopsy systems and breast MRI coils.

In addition to breast health, Hologic also offers products for cervical cancer screening, such as the ThinPrep Pap test and the Aptima HPV assay. The company also offers products for osteoporosis diagnosis and treatment, including the Horizon DXA system and the Fluoroscan InSight FD mini C-arm.

Hologic has a strong commitment to research and development, with over 1,200 patents and patent applications worldwide. The company invests heavily in clinical studies to ensure the safety and efficacy of its products, and has a team of over 1,000 scientists and engineers working to develop new technologies.

Overall, Hologic is a leader in women's health, with a strong focus on early detection and treatment of diseases. The company's innovative products and commitment to research make it a valuable partner for healthcare providers and patients alike.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists HOLOGIC INC's shareholders in Q4 2021. To view HOLOGIC INC's shareholder history, click here.